U.S. Markets closed

Acceleron Pharma Inc. (XLRN)


NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
34.10+0.15 (+0.44%)
At close: 4:00PM EDT
People also watch
EPZMMGNXAGIOOMEDFPRX
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue27,77118,09714,632
Cost of Revenue---
Gross Profit27,77118,09714,632
Operating Expenses
Research Development68,58058,40450,897
Selling General and Administrative25,29720,57214,199
Non Recurring--5,000
Others---
Total Operating Expenses---
Operating Income or Loss-66,106-60,879-55,464
Income from Continuing Operations
Total Other Income/Expenses Net9,116-3,0155,127
Earnings Before Interest and Taxes-56,990-63,894-50,337
Interest Expense--922
Income Before Tax-56,990-63,894-51,259
Income Tax Expense24--
Minority Interest---
Net Income From Continuing Ops-57,014-63,894-51,259
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-57,014-63,894-51,259
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-57,014-63,894-51,259